P172712 amicus-B1 service contract for amicus apheresis machines serial #D0904M4055 and D0904M4062. See attached agreement number 40002631
Ended Purchase Order Awarded Last action
- Contract number
- HHSN269201000144P
- Awardee
-
Fenwal, Inc. UEI E9UHXHZCGJV5
- Awarding agency
-
Office of the Chief Operating Officer
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,000
Award facts
- Contract value 100% obligated
- $13,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
This purchase order, valued at $13,000, was awarded to Fenwal, Inc. on March 25, 2010, for service contract support of AMICUS-B1 apheresis machines (Serial #D0904M4055 and D0904M4062) at the National Institutes of Health Clinical Center in Bethesda, Maryland. The contract, which was funded through the Office of the Chief Operating Officer and had an ultimate completion date of May 4, 2011, was awarded without set-aside designation, reflecting Fenwal's specialized capabilities in apheresis equipment maintenance and support. As a subsidiary of Fresenius Kabi and a global blood technology company, Fenwal provided critical preventative maintenance services on specialized medical equipment essential to the NIH Clinical Center's blood banking and cell therapy operations.
Fenwal, Inc. has established itself as a key federal supplier to the NIH and other health-related government agencies through its extensive expertise in transfusion medicine and cell therapy technologies. The company's federal contract portfolio encompasses blood collection and separation products, storage solutions, and specialized apheresis equipment and consumables, with maintenance contracts extending through multiple years. This award represents part of Fenwal's ongoing commitment to support critical healthcare missions across the Department of Defense, Department of Veterans Affairs, National Institutes of Health, and other federal health agencies through firm fixed-price agreements.
Quick answers
Who was awarded contract HHSN269201000144P?
HHSN269201000144P was awarded to Fenwal, Inc. by Office of the Chief Operating Officer (National Institutes of Health) on March 25, 2010.
How much is contract HHSN269201000144P worth?
The government has obligated $13,000 on HHSN269201000144P.
Was contract HHSN269201000144P competed?
The extent of competition for HHSN269201000144P was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award